APA (7th ed.) Citation

Ahmed, F., Gaul, C., Kollewe, K., Singh, R. C., & Sommer, K. (2025). Real-World Safety and Efficacy of 156 U – 195 U OnabotulinumtoxinA in Adults With Chronic Migraine: Results From the REPOSE Study. BMC Neurology, 25(1), 1. https://doi.org/10.1186/s12883-025-04087-7

Chicago Style (17th ed.) Citation

Ahmed, Fayyaz, Charly Gaul, Katja Kollewe, Ritu C. Singh, and Katherine Sommer. "Real-World Safety and Efficacy of 156 U – 195 U OnabotulinumtoxinA in Adults With Chronic Migraine: Results From the REPOSE Study." BMC Neurology 25, no. 1 (2025): 1. https://doi.org/10.1186/s12883-025-04087-7.

MLA (9th ed.) Citation

Ahmed, Fayyaz, et al. "Real-World Safety and Efficacy of 156 U – 195 U OnabotulinumtoxinA in Adults With Chronic Migraine: Results From the REPOSE Study." BMC Neurology, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12883-025-04087-7.